Jeyachandran, S. Responsive afatinib treatment in high-grade salivary gland ductal carcinoma and NSCLC with uncommon EGFR mutations: Treatment outcomes. Elsevier.
Chicago Style (17th ed.) CitationJeyachandran, Sivakamavalli. Responsive Afatinib Treatment in High-grade Salivary Gland Ductal Carcinoma and NSCLC with Uncommon EGFR Mutations: Treatment Outcomes. Elsevier.
MLA (9th ed.) CitationJeyachandran, Sivakamavalli. Responsive Afatinib Treatment in High-grade Salivary Gland Ductal Carcinoma and NSCLC with Uncommon EGFR Mutations: Treatment Outcomes. Elsevier.
Warning: These citations may not always be 100% accurate.